Tower Research Capital LLC (Trc) Neuro Pace Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Neuro Pace Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,203 shares of NPCE stock, worth $13,401. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,203

Previous 4,411 72.73%

Holding current value

$13,401

Previous $33,000 75.76%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.65 - $8.46 $21,333 - $27,139	-3,208 Reduced 72.73%	1,203 $8,000
Q2 2024 Aug 13, 2024	BUY	$6.38 - $15.33 $4,134 - $9,933	648 Added 17.22%	4,411 $33,000
Q1 2024 May 15, 2024	BUY	$9.78 - $17.5 $34,337 - $61,442	3,511 Added 1393.25%	3,763 $49,000
Q4 2023 Feb 13, 2024	BUY	$5.9 - $10.31 $1,486 - $2,598	252 New	252 $2,000
Q2 2023 Aug 14, 2023	SELL	$3.98 - $5.12 $2,762 - $3,553	-694 Reduced 88.52%	90 $0
Q1 2023 May 09, 2023	SELL	$1.44 - $5.34 $7,096 - $26,315	-4,928 Reduced 86.27%	784 $4,000
Q4 2022 Feb 10, 2023	BUY	$1.29 - $3.67 $970 - $2,759	752 Added 15.16%	5,712 $9,000
Q3 2022 Nov 10, 2022	BUY	$3.1 - $5.98 $15,376 - $29,660	4,960 New	4,960 $19,000
Q2 2022 Aug 15, 2022	SELL	$4.95 - $8.7 $8,078 - $14,198	-1,632 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$7.06 - $11.57 $3,572 - $5,854	506 Added 44.94%	1,632 $13,000
Q4 2021 Feb 14, 2022	BUY	$8.63 - $17.36 $4,910 - $9,877	569 Added 102.15%	1,126 $11,000
Q3 2021 Nov 15, 2021	SELL	$15.85 - $25.07 $12,458 - $19,705	-786 Reduced 58.53%	557 $9,000
Q2 2021 Aug 16, 2021	BUY	$19.03 - $26.5 $25,557 - $35,589	1,343 New	1,343 $32,000

Others Institutions Holding NPCE

# of Institutions

Shares Held

21.3M

Call Options Held

1.3K

Put Options Held

100

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $277M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Neuro Pace Inc Transaction History